[1] |
LI Dong, SONG Yana, WANG Ligang, BIAN Rongrong, ZHAO Yan.
Considerations for Establishing National Sentinel Hospitals for Medical Device Adverse Event Monitoring
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 780-785.
|
[2] |
LIU Ming, ZHENG Li, ZHANG Weina, SUN Xuelin, TIAN Jinhui, ZHAO Yan.
Research Progress in Biological Activity and Mechanisms of Pachymic Acid
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 826-830.
|
[3] |
LIN Lin, YANG Tingyu, GAO Rong, MA Zengchun, SHEN Xin, GAO Yue.
Effects of Sinomenine in Brassica rapa L. against Hypoxic Pulmonary Vascular Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 608-613.
|
[4] |
LI Dong, ZHAO Yan.
Roles of National Arthroplasty Registries in Post-Market Surveillance of Medical Devices
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 640-644.
|
[5] |
LIANG Fanglin, CHEN Lingyuan, HU Danli, WEI Lingyun, WEI Tiemeng, ZHANG Faen, WEI Yana.
Immune-Related Adverse Events of Tislelizumab in 120 Patients with Hepatocellular Carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 659-663.
|
[6] |
SUN Xiaorui, ZHAO Ning, ZHANG Luyong, JIANG Zhenzhou, WANG Xinzhi.
Research Progress in Drug-Related Liver Injury in the Treatment of Autoimmune Diseases
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 523-527.
|
[7] |
CAO Weiping, ZHANG Shichao, NI Xia, XIE Bing, WANG Xinzhi, XING Mengtao.
Research Progress in Liver Injury Caused by Drugs Commonly Used during Pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 528-531.
|
[8] |
CHEN Qingyu, JIANG Zhenzhou, ZHANG Luyong.
Research Progress in Adaptive Response of Hepatocytes in Intrinsic Drug-Induced Liver Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 532-538.
|
[9] |
WANG Li, TANG Jinling, LI Cuihong, TAN Feilong, YOU Lina, ZHAO Fangyun.
One Case of Acute Severe Liver Injury Caused by High-Dose Dexamethasone Sodium Phosphate Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 589-591.
|
[10] |
CHEN Huan, LIANG Jun, ZHAO Wei, XIA Qingrong.
Clinical Features and Risk Factors of Liver Injury Induced by Atypical Antipsychotic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 410-414.
|
[11] |
CHEN Qi, ZHANG Mingqiang, GUO Jun.
One Case of Interstitial Pneumonia Caused by Imatinib Mesylate Tablets during the Treatment of Gastric Stromal Tumor
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 463-465.
|
[12] |
LONG Minjuan, ZHAO Xu, GUO Longxin, CAI Yuhan, LIN Li, ZHU Shengkai, LIU Wenlong, SONG Haibo, XIAO Xiaohe.
Big Data Analysis of Liver Adverse Reactions Monitoring of Chinese and Western Medicines Based on Age Correction and Risk Warning for Dermatologic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 271-275.
|
[13] |
YU Li, TAN Xiying.
One Case of Acute Hepatic Injury Caused by Ioversol Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 343-345.
|
[14] |
TANG Qianhui, ZHANG Haoran, ZHANG Luyong, JIANG Zhenzhou.
Research Progress in Triptolide-Induced Live Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 121-127.
|
[15] |
TANG Qianhui, ZHU Ying, ZHANG Haoran, ZHANG Luyong, JIANG Zhenzhou.
Roles of Hepatocellular NF-κB Signaling Pathway in Triptolide-Induced Indirect Liver Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 128-138.
|